S. Kunori

Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats.

T. Kitayama, N. Kimoto, J. Ikeda, 2016, Journal of pharmacological sciences.

Involvement of prostaglandin F2α receptor in ATP-induced mechanical allodynia

S. Matsumura, S. Ito, Y. Sugimoto, 2009, Neuroscience.

Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.

T. Kitayama, N. Kimoto, M. Uchii, 2016, European journal of pharmacology.

The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo.

A. Hamaguchi, T. Kitayama, N. Kimoto, 2017, Journal of pharmacological sciences.

Impairment of CaMKII activation and attenuation of neuropathic pain in mice lacking NR2B phosphorylated at Tyr1472

Masahiko Watanabe, S. Matsumura, E. Okuda‐Ashitaka, 2010, The European journal of neuroscience.

A novel role of prostaglandin E2 in neuropathic pain

L. Audoly, Y. Urade, S. Matsumura, 2011, Glia.